Picosun Oy, Finland-based global manufacturer of state-of-the-art Atomic Layer Deposition (ALD) equipment, has again proven its unparalleled expertise in ALD reactor design and manufacturing. Record particle levels, only 1-2 added particles (> 70 nm) per wafer have been obtained with the PICOSUN P-300B ALD batch tool installed at Fraunhofer Institute for Photonic Microsystems (Fraunhofer IPMS) in the center of European IC manufacturing industry in Dresden, Germany.
In its continued focus to utilize carbon nanomaterials to revolutionize advanced materials, Zyvex Technologies announced today, at Nanotech 2012 in Tokyo, the introduction of its advanced rubber technology, Zyvex Molecularly Engineered Rubber or ZyMER.
Nanologica leverages its carrier materials to play a key part in the four-year EU project, ORCHID. Led by GlaxoSmithKline (GSK), the project aims to discover and develop new medicines against multiple drug resistant tuberculosis.
Vorbeck, in partnership with the Pacific Northwest National Labs (PNNL) and Princeton University, is leading the effort to commercialize next generation lithium batteries incorporating graphene technology.
mPhase Technologies, Inc. said today that it has been developing intellectual property based on an innovative platform technology to control the flow of fluids by electronically manipulating the way liquids behave when in contact with a solid or porous surface.
Tegal Corporation today announced renewed efforts to make available the balance of its semiconductor process-related intellectual property portfolio. The remaining portfolio consists of thin film structures and process technology pertaining to copper barrier and low-k dielectric technology.
Konica Minolta IJ Technologies, Inc. announced today that the company developed KM128SNG-MB, a high precision inkjet printhead, with the first use of MEMS technology at Konica Minolta. KM128SNG-MB delivers tiny drop size (1 picoliter) for the first time for printed electronics applications.
The article, entitled Carbon Nanotubes: Solution for the Therapeutic Delivery of siRNA? highlights the use of carbon nanotubes for therapeutic applications and reports on the recent advances of Ensysce as it moves its technology toward IND enabling studies and a Phase 1 clinical trial.
Proceeds from the offering will be used for working capital and research and development related to Arrogene's diagnostic and therapeutic technologies for brain, breast and lung cancer. WestPark Capital acted as placement agent for the offering.
Brion Technologies, a division of ASML, today announces a new product for semiconductor manufacturers who need the most powerful computational lithography for the next node of chip manufacturing, for a new generation of faster and more energy-efficient electronic devices.
The aim of the internationalization award is to promote company activities in an international environment and their ability to develop and implement new operating models. It is also intended to encourage the winning companies' internationalization and that of other Finnish companies.